STRIMVELIS
Live / Allowed — Published for opposition (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79437594
- Mark type
- Stylized text
- Filed
- 08 Aug 2025
- Published for opposition
- 08 Sept 2026
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for gene therapy for the treatment of severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID); pharmaceutical preparations for the treatment of adenosine deaminase severe combined immunodeficiency (ADA-SCID) using autologous 34+ cells transduced to express adenosine deaminase (ADA); pharmaceutical preparations for treating ADA-SCID
- Class 042 — Scientific and technological services: Biological research, clinical research in the field of gene therapy and medical research; medical research laboratory services; research and development of vaccines and medicines; scientific research services in the preparation of biological samples f o r testing and analysis in research laboratories; genetic scientific research; scientific research and development; pharmaceutical drug development services; providing information on clinical studies via an interactive website; medical and scientific research, namely, conducting clinical trials for others; DNA screening for scientific research purposes; design and development of computer hardware and software; research and development of new products for others; conducting technical scientific feasibility project studies; rental of computer software for collecting, analysing and organizing data in the field of medical research and treatment of genetic diseases; computer programming; conversion of computer programs and data, other than physical conversion; recovery of computer data; quality control for others; material testing; engineering, namely, surveying; conversion of data or documents from physical to electronic media; bacteriological research; hosting of communication computer platforms on the internet; programming of software for Internet platforms; pharmaceutical products development; scientific research services; scientific laboratory services; structural and functional analysis of genomes; development of pharmaceutical preparations and medicines; scientific research consultancy in relation to assessments, estimates, and researches in science and technology rendered by engineers; providing information in the nature of evaluations and estimations in the field of medical research; industrial research and biological analysis in the field of health; providing of imaging and physiology platforms, namely, providing temporary use of online non-downloadable software for analysing medical imaging; research and development of pharmaceuticals and veterinary and hygiene preparations for others; product development and testing of pharmaceuticals in the validation of biological tests, cellular tests, genetic tests and immunological tests of others; gene therapy research and scientific research counselling, in relation to research services and therapy
- Class 044 — Medical, beauty and agricultural services: Medical services; medical screening; medical assistance; medical counselling; providing news and information in the field of medicine; performing diagnosis of diseases; medical advisory services relating to degenerative diseases; medical surgical diagnostic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic services; human hygiene and beauty care; health counselling; hospital services; nursing home services; pharmaceutical advice, namely, prescription management and reviews being medication counseling; medical imaging services; human tissue bank services; conducting of medical examinations; medical consultations; medical and health care services relating to DNA, genetics and genetic testing; telemedicine services; stem cell therapy services; preparation and dispensing of medications; providing of medical information in the pharmaceutical field; medical, alternative medicinal and pharmaceutical consultancy
Owner
Prosecution history
- 08 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Sept 2026 — PUBLISHED FOR OPPOSITION
- 02 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Aug 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Aug 2026 — EXAMINER'S AMENDMENT ENTERED
- 13 Aug 2026 — EXAMINERS AMENDMENT E-MAILED
- 13 Aug 2026 — EXAMINERS AMENDMENT -WRITTEN
- 20 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jul 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Feb 2026 — REFUSAL PROCESSED BY IB
- 26 Jan 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 26 Jan 2026 — REFUSAL PROCESSED BY MPU
- 23 Dec 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW